Maternal levels of acute phase proteins in early pregnancy and risk of autism spectrum disorders in offspring.
Journal
Translational psychiatry
ISSN: 2158-3188
Titre abrégé: Transl Psychiatry
Pays: United States
ID NLM: 101562664
Informations de publication
Date de publication:
07 04 2022
07 04 2022
Historique:
received:
09
03
2021
accepted:
21
03
2022
revised:
17
03
2022
entrez:
8
4
2022
pubmed:
9
4
2022
medline:
12
4
2022
Statut:
epublish
Résumé
Previous research supports a contribution of early-life immune disturbances in the etiology of autism spectrum disorders (ASD). Biomarker studies of the maternal innate (non-adaptive) immune status related to ASD risk have focused on one of the acute phase proteins (APP), C-reactive protein (CRP), with conflicting results. We evaluated levels of eight different APP in first-trimester maternal serum samples, from 318 mothers to ASD cases and 429 mothers to ASD-unaffected controls, nested within the register-based Stockholm Youth Cohort. While no overall associations between high levels of APP and ASD were observed, associations varied across diagnostic sub-groups based on co-occurring conditions. Maternal levels of CRP in the lowest compared to the middle tertile were associated with increased risk of ASD without ID or ADHD in offspring (OR = 1.92, 95% CI 1.08-3.42). Further, levels of maternal ferritin in the lowest (OR = 1.78, 95% CI 1.18-2.69) and highest (OR = 1.64, 95% CI 1.11-2.43) tertiles were associated with increased risk of any ASD diagnosis in offspring, with stronger associations still between the lowest (OR = 3.81, 95% CI 1.91-7.58) and highest (OR = 3.36, 95% CI 1.73-6.53) tertiles of ferritin and risk of ASD with ID. The biological interpretation of lower CRP levels among mothers to ASD cases is not clear but might be related to the function of the maternal innate immune system. The finding of aberrant levels of ferritin conferring risk of ASD-phenotypes indicates a plausibly important role of iron during neurodevelopment.
Identifiants
pubmed: 35393396
doi: 10.1038/s41398-022-01907-z
pii: 10.1038/s41398-022-01907-z
pmc: PMC8989993
doi:
Substances chimiques
Acute-Phase Proteins
0
C-Reactive Protein
9007-41-4
Ferritins
9007-73-2
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
148Informations de copyright
© 2022. The Author(s).
Références
Lyall K, Croen L, Daniels J, Fallin MD, Ladd-Acosta C, Lee BK, et al. The changing epidemiology of autism spectrum disorders. Annu Rev Public Health. 2017;38:81–102.
pubmed: 28068486
doi: 10.1146/annurev-publhealth-031816-044318
Lord C, Elsabbagh M, Baird G, Veenstra-Vanderweele J. Autism spectrum disorder. Lancet. 2018;392:508–20.
pubmed: 30078460
pmcid: 7398158
doi: 10.1016/S0140-6736(18)31129-2
Lai MC, Kassee C, Besney R, Bonato S, Hull L, Mandy W, et al. Prevalence of co-occurring mental health diagnoses in the autism population: a systematic review and meta-analysis. Lancet Psychiatry. 2019;6:819–29.
pubmed: 31447415
doi: 10.1016/S2215-0366(19)30289-5
Xie S, Karlsson H, Dalman C, Widman L, Rai D, Gardner RM, et al. The familial risk of autism spectrum disorder with and without intellectual disability. Autism Res. 2020;13:2242-2250.
LaBianca S, Brikell I, Helenius D, Loughnan R, Mefford J, Palmer CE, et al. Polygenic profiles define aspects of clinical heterogeneity in ADHD. 2021. https://www.medrxiv.org/content/10.1101/2021.07.13.21260299v1 .
Saghazadeh A, Ataeinia B, Keynejad K, Abdolalizadeh A, Hirbod-Mobarakeh A, Rezaei N. A meta-analysis of pro-inflammatory cytokines in autism spectrum disorders: effects of age, gender, and latitude. J Psychiatr Res. 2019;115:90–102.
pubmed: 31125917
doi: 10.1016/j.jpsychires.2019.05.019
Deverman BE, Patterson PH. Cytokines and CNS development. Neuron. 2009;64:61–78.
pubmed: 19840550
doi: 10.1016/j.neuron.2009.09.002
Boulanger LM. Immune proteins in brain development and synaptic plasticity. Neuron. 2009;64:93–109.
pubmed: 19840552
doi: 10.1016/j.neuron.2009.09.001
Onore C, Careaga M, Ashwood P. The role of immune dysfunction in the pathophysiology of autism. Brain Behav Immun. 2012;26:383–92.
pubmed: 21906670
doi: 10.1016/j.bbi.2011.08.007
Careaga M, Murai T, Bauman MD. Maternal immune activation and autism spectrum disorder: from rodents to nonhuman and human primates. Biol Psychiatry. 2017;81:391–401.
pubmed: 28137374
doi: 10.1016/j.biopsych.2016.10.020
Han VX, Patel S, Jones HF, Dale RC. Maternal immune activation and neuroinflammation in human neurodevelopmental disorders. Nat Rev Neurol. 2021;17:564–79.
pubmed: 34341569
doi: 10.1038/s41582-021-00530-8
Ji-Xu A, Vincent A. Maternal immunity in autism spectrum disorders: questions of causality, validity, and specificity. J Clin Med. 2020;9:2590.
Chen SW, Zhong XS, Jiang LN, Zheng XY, Xiong YQ, Ma SJ, et al. Maternal autoimmune diseases and the risk of autism spectrum disorders in offspring: a systematic review and meta-analysis. Behav Brain Res. 2016;296:61–69.
pubmed: 26327239
doi: 10.1016/j.bbr.2015.08.035
Lei XY, Li YJ, Ou JJ, Li YM. Association between parental body mass index and autism spectrum disorder: a systematic review and meta-analysis. Eur Child Adolesc Psychiatry. 2019;28:933–47.
pubmed: 30470952
doi: 10.1007/s00787-018-1259-0
Jiang HY, Xu LL, Shao L, Xia RM, Yu ZH, Ling ZX, et al. Maternal infection during pregnancy and risk of autism spectrum disorders: a systematic review and meta-analysis. Brain Behav Immun. 2016;58:165–72.
pubmed: 27287966
doi: 10.1016/j.bbi.2016.06.005
Wiegersma AM, Dalman C, Lee BK, Karlsson H, Gardner RM. Association of prenatal maternal anemia with neurodevelopmental disorders. JAMA Psychiatry. 2019:76:1294-1304.
Lee BK, Eyles DW, Magnusson C, Newschaffer CJ, McGrath JJ, Kvaskoff D, et al. Developmental vitamin D and autism spectrum disorders: findings from the Stockholm Youth Cohort. Mol Psychiatry. 2021;26:1578-1588.
Yip BHK, Bai D, Mahjani B, Klei L, Pawitan Y, Hultman CM, et al. Heritable variation, with little or no maternal effect, accounts for recurrence risk to autism spectrum disorder in Sweden. Biol Psychiatry. 2018;83:589–97.
pubmed: 29100626
doi: 10.1016/j.biopsych.2017.09.007
Gardner RM, Lee BK, Magnusson C, Rai D, Frisell T, Karlsson H, et al. Maternal body mass index during early pregnancy, gestational weight gain, and risk of autism spectrum disorders: results from a Swedish total population and discordant sibling study. Int J Epidemiol. 2015;44:870–83.
pubmed: 26045508
pmcid: 4521130
doi: 10.1093/ije/dyv081
Tylee DS, Sun J, Hess JL, Tahir MA, Sharma E, Malik R, et al. Genetic correlations among psychiatric and immune-related phenotypes based on genome-wide association data. Am J Med Genet Part B, Neuropsychiatr Genet. 2018;177:641–57.
doi: 10.1002/ajmg.b.32652
Jones KL, Croen LA, Yoshida CK, Heuer L, Hansen R, Zerbo O, et al. Autism with intellectual disability is associated with increased levels of maternal cytokines and chemokines during gestation. Mol Psychiatry. 2017;22:273-279.
Krakowiak P, Goines PE, Tancredi DJ, Ashwood P, Hansen RL, Hertz-Picciotto I, et al. Neonatal Cytokine Profiles Associated with Autism Spectrum Disorder. Biol Psychiatry. 2017;81:442-451.
Abdallah MW, Larsen N, Mortensen EL, Atladottir HO, Norgaard-Pedersen B, Bonefeld-Jorgensen EC, et al. Neonatal levels of cytokines and risk of autism spectrum disorders: an exploratory register-based historic birth cohort study utilizing the Danish Newborn Screening Biobank. J Neuroimmunol. 2012;252:75–82.
pubmed: 22917523
doi: 10.1016/j.jneuroim.2012.07.013
Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999;340:448–54.
pubmed: 9971870
doi: 10.1056/NEJM199902113400607
Wang W, Knovich MA, Coffman LG, Torti FM, Torti SV. Serum ferritin: past, present and future. Biochim Biophys Acta. 2010;1800:760–9.
pubmed: 20304033
pmcid: 2893236
doi: 10.1016/j.bbagen.2010.03.011
Mosesson MW. Fibrinogen and fibrin structure and functions. J Thromb Haemost. 2005;3:1894–904.
pubmed: 16102057
doi: 10.1111/j.1538-7836.2005.01365.x
Sack GH Jr. Serum amyloid A - a review. Mol Med. 2018;24:46.
pubmed: 30165816
pmcid: 6117975
doi: 10.1186/s10020-018-0047-0
Brown AS, Sourander A, Hinkka-Yli-Salomäki S, McKeague IW, Sundvall J, Surcel HM. Elevated maternal C-reactive protein and autism in a national birth cohort. Mol Psychiatry. 2014;19:259–64.
pubmed: 23337946
doi: 10.1038/mp.2012.197
Zerbo O, Traglia M, Yoshida C, Heuer LS, Ashwood P, Delorenze GN, et al. Maternal mid-pregnancy C-reactive protein and risk of autism spectrum disorders: the early markers for autism study. Transl Psychiatry. 2016;6:e783.
pubmed: 27093065
pmcid: 4872404
doi: 10.1038/tp.2016.46
Koks N, Ghassabian A, Greaves-Lord K, Hofman A, Jaddoe VW, Verhulst FC, et al. Maternal C-reactive protein concentration in early pregnancy and child autistic traits in the general population. Paediatr Perinat Epidemiol. 2016;30:181–9.
pubmed: 26860445
doi: 10.1111/ppe.12261
Egorova O, Myte R, Schneede J, Hägglöf B, Bölte S, Domellöf E, et al. Maternal blood folate status during early pregnancy and occurrence of autism spectrum disorder in offspring: a study of 62 serum biomarkers. Mol Autism. 2020;11:7.
pubmed: 32131900
pmcid: 6964211
doi: 10.1186/s13229-020-0315-z
Idring S, Rai D, Dal H, Dalman C, Sturm H, Zander E, et al. Autism spectrum disorders in the Stockholm Youth Cohort: design, prevalence and validity. PLoS ONE. 2012;7:e41280.
pubmed: 22911770
pmcid: 3401114
doi: 10.1371/journal.pone.0041280
Gardner RM, Lee BK, Brynge M, Sjöqvist H, Dalman C, Karlsson H. Neonatal levels of acute phase proteins and risk of autism spectrum disorder. Biol Psychiatry. 2021;89:463-475.
Haram K, Augensen K, Elsayed S. Serum protein pattern in normal pregnancy with special reference to acute-phase reactants. Br J Obstet Gynaecol. 1983;90:139–45.
pubmed: 6600623
doi: 10.1111/j.1471-0528.1983.tb08898.x
Kalhan SC. Protein metabolism in pregnancy. Am J Clin Nutr. 2000;71:1249S–1255S.
pubmed: 10799398
doi: 10.1093/ajcn/71.5.1249s
Orsini N, Greenland S. A Procedure to Tabulate and Plot Results after Flexible Modeling of a Quantitative Covariate. The Stata Journal 2011;11:1–29.
Chudal R, Brown AS, Gyllenberg D, Hinkka-Yli-Salomäki S, Sucksdorff M, Surcel H-M, et al. Maternal serum C-reactive protein (CRP) and offspring attention deficit hyperactivity disorder (ADHD). Eur Child Adolesc Psychiatry. 2020;29:239–47.
pubmed: 31312974
doi: 10.1007/s00787-019-01372-y
Freeman MS, Mansfield MW, Barrett JH, Grant PJ. Genetic contribution to circulating levels of hemostatic factors in healthy families with effects of known genetic polymorphisms on heritability. Arterioscler Thromb Vasc Biol. 2002;22:506–10.
pubmed: 11884298
doi: 10.1161/hq0302.104906
Souto JC, Almasy L, Borrell M, Garí M, Martínez E, Mateo J, et al. Genetic determinants of hemostasis phenotypes in Spanish families. Circulation. 2000;101:1546–51.
pubmed: 10747348
doi: 10.1161/01.CIR.101.13.1546
Sas AA, Vaez A, Jamshidi Y, Nolte IM, Kamali Z, DS T, et al. Genetic and environmental influences on stability and change in baseline levels of C-reactive protein: a longitudinal twin study. Atherosclerosis. 2017;265:172–8.
pubmed: 28892714
doi: 10.1016/j.atherosclerosis.2017.08.008
Choi J, Joseph L, Pilote L. Obesity and C-reactive protein in various populations: a systematic review and meta-analysis. Obes Rev. 2013;14:232–44.
pubmed: 23171381
doi: 10.1111/obr.12003
Malle E, Steinmetz A, Raynes JG. Serum amyloid A (SAA): an acute phase protein and apolipoprotein. Atherosclerosis. 1993;102:131–46.
pubmed: 7504491
doi: 10.1016/0021-9150(93)90155-N
Sproston NR, Ashworth JJ. Role of C-reactive protein at sites of inflammation and infection. Front Immunol. 2018;9:754.
pubmed: 29706967
pmcid: 5908901
doi: 10.3389/fimmu.2018.00754
Pepys MB, Booth DR, Hutchinson WL, Gallimore JR, Collins IM, Hohenester E. Amyloid P component. A critical review. Amyloid. 1997;4:274–95.
doi: 10.3109/13506129709003838
Gandal MJ, Haney JR, Parikshak NN, Leppa V, Ramaswami G, Hartl C, et al. Shared molecular neuropathology across major psychiatric disorders parallels polygenic overlap. Science. 2018;359:693–7.
pubmed: 29439242
pmcid: 5898828
doi: 10.1126/science.aad6469
Autism Spectrum Disorders Working Group of The Psychiatric Genomics Consortium. Meta-analysis of GWAS of over 16,000 individuals with autism spectrum disorder highlights a novel locus at 10q24.32 and a significant overlap with schizophrenia. Mol Autism. 2017;8:21.
Ligthart S, Vaez A, Vosa U, Stathopoulou MG, de Vries PS, Prins BP, et al. Genome analyses of >200,000 individuals identify 58 loci for chronic inflammation and highlight pathways that link inflammation and complex disorders. Am J Hum Genet. 2018;103:691–706.
pubmed: 30388399
pmcid: 6218410
doi: 10.1016/j.ajhg.2018.09.009
Gardner RM, Dalman C, Wicks S, Lee BK, Karlsson H. Neonatal levels of acute phase proteins and later risk of non-affective psychosis. Transl Psychiatry. 2013;3:e228.
pubmed: 23423137
pmcid: 3591005
doi: 10.1038/tp.2013.5
Lopez A, Cacoub P, Macdougall IC, Peyrin-Biroulet L. Iron deficiency anaemia. Lancet. 2016;387:907–16.
pubmed: 26314490
doi: 10.1016/S0140-6736(15)60865-0
Georgieff MK. Iron deficiency in pregnancy. Am J Obstet Gynecol. 2020;223:516–24.
pubmed: 32184147
pmcid: 7492370
doi: 10.1016/j.ajog.2020.03.006
Bastian TW, von Hohenberg WC, Mickelson DJ, Lanier LM, Georgieff MK. Iron deficiency impairs developing hippocampal neuron gene expression, energy metabolism, and dendrite complexity. Dev Neurosci. 2016;38:264–76.
pubmed: 27669335
doi: 10.1159/000448514
Ortiz E, Pasquini JM, Thompson K, Felt B, Butkus G, Beard J, et al. Effect of manipulation of iron storage, transport, or availability on myelin composition and brain iron content in three different animal models. J Neurosci Res. 2004;77:681–9.
pubmed: 15352214
doi: 10.1002/jnr.20207
Brunette KE, Tran PV, Wobken JD, Carlson ES, Georgieff MK. Gestational and neonatal iron deficiency alters apical dendrite structure of CA1 pyramidal neurons in adult rat hippocampus. Dev Neurosci. 2010;32:238–48.
pubmed: 20689287
pmcid: 3214841
doi: 10.1159/000314341
Schmidt RJ, Tancredi DJ, Krakowiak P, Hansen RL, Ozonoff S. Maternal intake of supplemental iron and risk of autism spectrum disorder. Am J Epidemiol. 2014;180:890–900.
pubmed: 25249546
pmcid: 4207718
doi: 10.1093/aje/kwu208
Rahman MM, Abe SK, Rahman MS, Kanda M, Narita S, Bilano V, et al. Maternal anemia and risk of adverse birth and health outcomes in low- and middle-income countries: systematic review and meta-analysis. Am J Clin Nutr. 2016;103:495–504.
pubmed: 26739036
doi: 10.3945/ajcn.115.107896
Dewey KG, Oaks BM. U-shaped curve for risk associated with maternal hemoglobin, iron status, or iron supplementation. Am J Clin Nutr. 2017;106:1694s–1702s.
pubmed: 29070565
pmcid: 5701708
doi: 10.3945/ajcn.117.156075
Siddappa AM, Georgieff MK, Wewerka S, Worwa C, Nelson CA, Deregnier RA. Iron deficiency alters auditory recognition memory in newborn infants of diabetic mothers. Pediatr Res. 2004;55:1034–41.
pubmed: 15155871
doi: 10.1203/01.pdr.0000127021.38207.62
Geng F, Mai X, Zhan J, Xu L, Zhao Z, Georgieff M, et al. Impact of fetal-neonatal iron deficiency on recognition memory at 2 months of age. J Pediatr. 2015;167:1226–32.
pubmed: 26382625
pmcid: 4662910
doi: 10.1016/j.jpeds.2015.08.035
Tamura T, Goldenberg RL, Hou J, Johnston KE, Cliver SP, Ramey SL, et al. Cord serum ferritin concentrations and mental and psychomotor development of children at five years of age. J Pediatr. 2002;140:165–70.
pubmed: 11865266
doi: 10.1067/mpd.2002.120688
Steer P, Alam MA, Wadsworth J, Welch A. Relation between maternal haemoglobin concentration and birth weight in different ethnic groups. BMJ (Clin Res Ed). 1995;310:489–91.
doi: 10.1136/bmj.310.6978.489
Casanueva E, Viteri FE. Iron and oxidative stress in pregnancy. J Nutr. 2003;133:1700s–1708s.
pubmed: 12730487
doi: 10.1093/jn/133.5.1700S
Drakesmith H, Prentice AM. Hepcidin and the iron-infection axis. Science. 2012;338:768–72.
pubmed: 23139325
doi: 10.1126/science.1224577
Pateva IB, Kerling EH, Reddy M, Chen D, Carlson SE, Tancabelic J. Effect of maternal cigarette smoking on newborn iron stores. Clin Res Trials. 2015;1:4–7.
pubmed: 26090215
pmcid: 4469279
Perneger TV. What’s wrong with Bonferroni adjustments. BMJ (Clin Res Ed). 1998;316:1236–8.
doi: 10.1136/bmj.316.7139.1236
Magnusson C, Rai D, Goodman A, Lundberg M, Idring S, Svensson A, et al. Migration and autism spectrum disorder: population-based study. Br J Psychiatry. 2012;201:109–15.
pubmed: 22361019
doi: 10.1192/bjp.bp.111.095125
Morinaga M, Rai D, Hollander AC, Petros N, Dalman C, Magnusson C. Migration or ethnic minority status and risk of autism spectrum disorders and intellectual disability: systematic review. Eur J Public Health. 2021;31:304–12.
pubmed: 33049777
doi: 10.1093/eurpub/ckaa108
Pilz V, Wolf K, Breitner S, Rückerl R, Koenig W, Rathmann W, et al. C-reactive protein (CRP) and long-term air pollution with a focus on ultrafine particles. Int J Hyg Environ Health. 2018;221:510–8.
pubmed: 29428699
doi: 10.1016/j.ijheh.2018.01.016
Gong T, Dalman C, Wicks S, Dal H, Magnusson C, Lundholm C, et al. Perinatal exposure to traffic-related air pollution and autism spectrum disorders. Environ Health Perspect. 2017;125:119–26.
pubmed: 27494442
doi: 10.1289/EHP118
Volk HE, Lurmann F, Penfold B, Hertz-Picciotto I, McConnell R. Traffic-related air pollution, particulate matter, and autism. JAMA Psychiatry. 2013;70:71–77.
pubmed: 23404082
pmcid: 4019010
doi: 10.1001/jamapsychiatry.2013.266
Volk HE, Park B, Hollingue C, Jones KL, Ashwood P, Windham GC, et al. Maternal immune response and air pollution exposure during pregnancy: insights from the Early Markers for Autism (EMA) study. J Neurodev Disord. 2020;12:42.
pubmed: 33327930
pmcid: 7745402
doi: 10.1186/s11689-020-09343-0